Telegenetics for inherited retinal diseases in the COVID-19 environment

Abstract Inherited retinal diseases (IRDs) are visually debilitating conditions that affect families worldwide. They require extensive clinical testing, examination, and patient and family counseling, which are frequently accomplished over single-day extended clinic visits. However, the COVID-19 pan...

Full description

Bibliographic Details
Main Authors: Ahmad Al-Moujahed, Aarushi Kumar, Teja Chemudupati, Stephen H. Tsang, Vinit B. Mahajan
Format: Article
Language:English
Published: BMC 2021-03-01
Series:International Journal of Retina and Vitreous
Subjects:
Online Access:https://doi.org/10.1186/s40942-021-00301-z
_version_ 1818439073019199488
author Ahmad Al-Moujahed
Aarushi Kumar
Teja Chemudupati
Stephen H. Tsang
Vinit B. Mahajan
author_facet Ahmad Al-Moujahed
Aarushi Kumar
Teja Chemudupati
Stephen H. Tsang
Vinit B. Mahajan
author_sort Ahmad Al-Moujahed
collection DOAJ
description Abstract Inherited retinal diseases (IRDs) are visually debilitating conditions that affect families worldwide. They require extensive clinical testing, examination, and patient and family counseling, which are frequently accomplished over single-day extended clinic visits. However, the COVID-19 pandemic has limited the number of patients and staff allowed in clinics, leading to interruptions in care. We therefore developed telehealth management protocols for complete or hybrid virtual visits. The three main components of our telegenetics approach included reviewing the diagnostic tests results remotely, in-person or virtual video visits with a retina specialist, and virtual genetic testing using saliva kits. During the first 5 months of the program, telegenetic care was provided for 80 patients, including 3 international patients, and a spectrum of retinal dystrophies were diagnosed and managed. In conclusion, telegenetic virtual visits ensure continuity of care while reducing patient and provider exposure to SARS-CoV-2 and may continue and expand into other medical genetic conditions long after the pandemic.
first_indexed 2024-12-14T17:50:39Z
format Article
id doaj.art-b1b5889aa2fd4f4db0bebe1e6780f593
institution Directory Open Access Journal
issn 2056-9920
language English
last_indexed 2024-12-14T17:50:39Z
publishDate 2021-03-01
publisher BMC
record_format Article
series International Journal of Retina and Vitreous
spelling doaj.art-b1b5889aa2fd4f4db0bebe1e6780f5932022-12-21T22:52:39ZengBMCInternational Journal of Retina and Vitreous2056-99202021-03-01711310.1186/s40942-021-00301-zTelegenetics for inherited retinal diseases in the COVID-19 environmentAhmad Al-Moujahed0Aarushi Kumar1Teja Chemudupati2Stephen H. Tsang3Vinit B. Mahajan4Molecular Surgery Laboratory, Department of Ophthalmology, Byers Eye Institute, Stanford UniversityMolecular Surgery Laboratory, Department of Ophthalmology, Byers Eye Institute, Stanford UniversityMolecular Surgery Laboratory, Department of Ophthalmology, Byers Eye Institute, Stanford UniversityDepartment of Ophthalmology, Columbia UniversityMolecular Surgery Laboratory, Department of Ophthalmology, Byers Eye Institute, Stanford UniversityAbstract Inherited retinal diseases (IRDs) are visually debilitating conditions that affect families worldwide. They require extensive clinical testing, examination, and patient and family counseling, which are frequently accomplished over single-day extended clinic visits. However, the COVID-19 pandemic has limited the number of patients and staff allowed in clinics, leading to interruptions in care. We therefore developed telehealth management protocols for complete or hybrid virtual visits. The three main components of our telegenetics approach included reviewing the diagnostic tests results remotely, in-person or virtual video visits with a retina specialist, and virtual genetic testing using saliva kits. During the first 5 months of the program, telegenetic care was provided for 80 patients, including 3 international patients, and a spectrum of retinal dystrophies were diagnosed and managed. In conclusion, telegenetic virtual visits ensure continuity of care while reducing patient and provider exposure to SARS-CoV-2 and may continue and expand into other medical genetic conditions long after the pandemic.https://doi.org/10.1186/s40942-021-00301-zTelegeneticsCOVID-19RetinaInherited retinal diseasesIRDsTelemedicine
spellingShingle Ahmad Al-Moujahed
Aarushi Kumar
Teja Chemudupati
Stephen H. Tsang
Vinit B. Mahajan
Telegenetics for inherited retinal diseases in the COVID-19 environment
International Journal of Retina and Vitreous
Telegenetics
COVID-19
Retina
Inherited retinal diseases
IRDs
Telemedicine
title Telegenetics for inherited retinal diseases in the COVID-19 environment
title_full Telegenetics for inherited retinal diseases in the COVID-19 environment
title_fullStr Telegenetics for inherited retinal diseases in the COVID-19 environment
title_full_unstemmed Telegenetics for inherited retinal diseases in the COVID-19 environment
title_short Telegenetics for inherited retinal diseases in the COVID-19 environment
title_sort telegenetics for inherited retinal diseases in the covid 19 environment
topic Telegenetics
COVID-19
Retina
Inherited retinal diseases
IRDs
Telemedicine
url https://doi.org/10.1186/s40942-021-00301-z
work_keys_str_mv AT ahmadalmoujahed telegeneticsforinheritedretinaldiseasesinthecovid19environment
AT aarushikumar telegeneticsforinheritedretinaldiseasesinthecovid19environment
AT tejachemudupati telegeneticsforinheritedretinaldiseasesinthecovid19environment
AT stephenhtsang telegeneticsforinheritedretinaldiseasesinthecovid19environment
AT vinitbmahajan telegeneticsforinheritedretinaldiseasesinthecovid19environment